| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 28,359 | 32,601 | 34,904 | 50,421 | | Cost of Revenue | 20,088 | 21,442 | 22,631 | 32,006 | | | Gross Profit | 8,271 | 11,159 | 12,273 | 18,415 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,008 | 6,527 | 6,172 | 7,589 | | Non Recurring | 164 | 73 |
-
| 25,464 | | Others | 3,365 | 3,443 | 3,337 | 3,537 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (266) | 1,116 | 2,764 | (18,175) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 18 | 8 | (10) | 148 | | Earnings Before Interest And Taxes | (248) | 1,124 | 2,754 | (18,027) | | Interest Expense | 691 | 683 | 1,040 | 1,595 | | Income Before Tax | (939) | 441 | 1,714 | (19,622) | | Income Tax Expense | (94) | 206 | 784 | (535) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (845) | 235 | 930 | (19,087) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (845) | 235 | 930 | (19,087) | | Preferred Stock And Other Adjustments | (122) | (121) | (120) | (122) | | | Net Income Applicable To Common Shares | ($967) | $114 | $810 | ($19,209) |
|
0.03% Nasdaq 
0.14 (10.37%) 
Income Statement
